Neurotoxicity

• University of British Columbia

  1 trialPhase 4124 people

• University of California, Davis

  1 trialPhase 464 people

• Medical University of South Carolina

  1 trialPhase 430 people

• Alliance for Clinical Trials in Oncology

  5 trialsPhase 3909 people

• Radiation Therapy Oncology Group

  2 trialsPhase 3645 people

• Gary Morrow

  1 trialPhase 3462 people

• University College London

  2 trialsPhase 251 people

• University College London (UCL) Cancer Institute

  2 trialsPhase 251 people

National Institute of Neurological Disorders and StrokeUS$3.9mNational Cancer InstituteUS$600.9kNational Institute of General Medical SciencesUS$443.1k

• Neurotoxicity due to Environmental complex Metal Mixtures Exposure

  National Institute of Neurological Disorders and StrokeJohns Hopkins UniversityUS$725.3k2022–2027

• Microbiota, Immunity and Neurotoxicity of Anesthesia and Surgery

  National Institute of General Medical SciencesMassachusetts General HospitalUS$443.1k2026–2031

• Neurotoxicity of particulate matter and its interaction with APOE in neurodegeneration

  National Institute of Neurological Disorders and StrokeUniversity of California-irvineUS$668.2k2022–2027

• Metformin to prevent chemotherapy-induced neurotoxicity among children with leukemia

  National Cancer InstituteRutgers Biomedical and Health SciencesUS$600.9k2026–2031

• Functional Analysis of Late-onset Alzheimer’s Disease-Associated Genes in Neurodegeneration and Protein Aggregation-induced Neurotoxicity

  National Institute on AgingMedical College of WisconsinUS$312k2025–2027

• Neurotoxicity of Spermine Synthase-deficiency and Polyamine Imbalance

  National Institute of Neurological Disorders and StrokeUniversity of ChicagoUS$910k2023–2026